Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
CALCIUM GLUCONATE
LAPIDOT MEDICAL IMPORT AND MARKETING LTD
A12AA03
SOLUTION FOR INJECTION
CALCIUM GLUCONATE 0.94 G / 10 ML
I.V
Required
B.BRAUN MELSUNGEN AG, GERMANY
CALCIUM GLUCONATE
CALCIUM GLUCONATE
Treatment of acute symptomatic hypocalcaemia.
2023-05-31
570/12394629/0213 schwarz Format = 210 x 297 mm (A4) 2 Seiten Lätus IL___570 570/12394629/0213 Calcium Gluconate 10% Injection B.P. MP – GIF Standort Berlin G 080624 B|BRAUN Calcium is insoluble in adipose tissue and may therefore cause infiltra- tion and subsequent abscess formation, tissue induration and necrosis. After perivascular or superficial IM injection local irritation, possibly fol- lowed by skin ablation or tissue necrosis, may occur, see also section “UNDESIRABLE EFFECTS”. Extravasation must be avoided; the injection site should be monitored carefully. High Vitamin D intake should be avoided. PREGNANCY AND LACTATION _Pregnancy:_ Calcium passes across the placental barrier and its concentration in fetal blood is higher than in maternal blood. Calcium gluconate injections should be used during pregnancy only if considered to be essential by the physician. The administered dose should be carefully calculated, and the serum calcium level regularly evaluated in order to avoid hypercalcaemia, which may be deleterious for the foetus. _Lactation:_ Calcium is excreted in breast milk This should be borne in mind when administering calcium to women who are breast-feeding their infants. INTERACTIONS The effects of _digoxin_ and other _cardiac glycosides_ may be potentiated by calcium, which may result in serious toxicity. Therefore, intravenous administration of calcium preparations to patients under therapy with cardiac glycosides is contraindicated. The only exception may be that IV calcium administration is imperative for treatment of severe hypoc- alcaemia symptoms putting the patient at immediate vital risk, if safer therapeutic alternatives are not available and calcium administration via the oral route is not possible (see also sections “CONTRAINDICATIONS” and “SPECIAL WARNINGS …”). Co-administration of calcium and _epinephrine_ may lead to cardiac ar- rhythmia. Calcium and _magnesium_ mutually antagonise their effects. Calcium may antagonise the effect of _ calcium antagonists_ (calcium Lugege kogu dokumenti